Abstract
patient records, nursing and medical notes. Data analysed using SPSS version 22. Results: Twenty-one patients with 26 TiLOOP assisted reconstructions with a mean follow up of 194 days (range 9e430) were analysed. Patients were a median age 51 (range 32e79) and median BMI of 25 (range 21e34). The majority had physical hobbies (n 1⁄4 16), no major comorbidities (n 1⁄4 17) and one was a smoker. The majority (n 1⁄4 19) stated the desire for a simple reconstructive option and were satisfied with their current breast size (n 1⁄4 18). 19 had in-situ or invasive breast cancer (n 1⁄4 13 screen-detected), 2 were risk reducing (proven BRCA mutation). Complications included: 1 haematoma; 5 seromas requiring single (40e150ml) aspiration; 3 with seroma treated as suspected minor infection with oral antibiotics. One implant loss was seen in this series. There was no correlation of complications with cup size, comorbidities or smoking status. Conclusions: TiLOOP is an economical non-autologous material available to provide lower-pole support and facilitate one-stage implantbased IBR, which is associated with a low complication rate.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
